A new trading day began on Friday, with Arvinas Inc (NASDAQ: ARVN) stock price up 6.71% from the previous day of trading, before settling in for the closing price of $7.75. ARVN’s price has ranged from $5.90 to $29.61 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -5.32% over the past five years. Meanwhile, its annual earnings per share averaged 65.46%. With a float of $64.24 million, this company’s outstanding shares have now reached $73.20 million.
Arvinas Inc (ARVN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arvinas Inc is 12.46%, while institutional ownership is 92.06%. The most recent insider transaction that took place on Sep 22 ’25, was worth 227,010. In this transaction Director of this company bought 30,000 shares at a rate of $7.57, taking the stock ownership to the 76,021 shares. Before that another transaction happened on Jun 24 ’25, when Company’s Chief Financial Officer sold 5,700 for $7.61, making the entire transaction worth $43,377. This insider now owns 164,401 shares in total.
Arvinas Inc (ARVN) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.68 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.50% during the next five years compared to -5.32% drop over the previous five years of trading.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Here are Arvinas Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach -2.90 in one year’s time.
Technical Analysis of Arvinas Inc (ARVN)
Arvinas Inc (NASDAQ: ARVN) saw its 5-day average volume 2.82 million, a positive change from its year-to-date volume of 2.13 million. As of the previous 9 days, the stock’s Stochastic %D was 62.61%.
During the past 100 days, Arvinas Inc’s (ARVN) raw stochastic average was set at 93.68%, which indicates a significant increase from 85.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was lower than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.49, while its 200-day Moving Average is $10.91. Nevertheless, the first resistance level for the watch stands at $8.56 in the near term. At $8.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.26. If the price goes on to break the first support level at $7.86, it is likely to go to the next support level at $7.44. Assuming the price breaks the second support level, the third support level stands at $7.16.
Arvinas Inc (NASDAQ: ARVN) Key Stats
With a market capitalization of 607.16 million, the company has a total of 73,418K Shares Outstanding. Currently, annual sales are 263,400 K while annual income is -198,900 K. The company’s previous quarter sales were 22,400 K while its latest quarter income was -61,200 K.
